SecSonar.com

Alvotech (ALVO)

Alvotech at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Alvotech (ALVO) is a Drug Manufacturers - Specialty & Generic company based in IS with a market capitalization of $1.1B. Revenue grew 19.7% year-over-year and free cash flow was negative at -$114.7M. This page tracks ALVO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IS · 1.01K employees · IPO Jun 16, 2022

Valuation

Valuation & price

$3.46 · as of May 26, 2026 · -64.7% vs 52w high

34.6

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.72$6.42$3.11Jul 25Dec 25Jul 26Jul 7, 25$9.02Jul 9, 25$8.74Jul 11, 25$8.52Jul 15, 25$8.41Jul 17, 25$8.73Jul 21, 25$8.64Jul 23, 25$9.16Jul 25, 25$9.61Jul 29, 25$9.72Jul 31, 25$9.06Aug 4, 25$8.87Aug 6, 25$8.46Aug 11, 25$8.52Aug 13, 25$8.96Aug 15, 25$8.03Aug 19, 25$8.69Aug 21, 25$8.47Aug 25, 25$8.32Aug 27, 25$8.03Aug 29, 25$8.07Sep 3, 25$7.95Sep 5, 25$8.33Sep 9, 25$8.11Sep 11, 25$8.05Sep 16, 25$7.96Sep 18, 25$7.82Sep 22, 25$8.01Sep 24, 25$8.58Sep 26, 25$8.34Sep 30, 25$8.19Oct 2, 25$8.20Oct 6, 25$8.58Oct 8, 25$8.68Oct 10, 25$8.24Oct 14, 25$8.50Oct 16, 25$8.75Oct 21, 25$8.52Oct 23, 25$8.15Oct 27, 25$8.13Oct 29, 25$7.90Oct 31, 25$7.65Nov 4, 25$4.83Nov 6, 25$5.06Nov 10, 25$5.48Nov 12, 25$5.60Nov 14, 25$5.49Nov 18, 25$5.11Nov 20, 25$5.06Nov 25, 25$5.34Nov 28, 25$5.10Dec 2, 25$4.60Dec 4, 25$5.07Dec 8, 25$5.45Dec 10, 25$5.53Dec 12, 25$5.57Dec 16, 25$5.04Dec 18, 25$4.73Dec 22, 25$4.94Dec 24, 25$5.29Dec 29, 25$4.97Jan 2, 26$5.00Jan 6, 26$4.58Jan 8, 26$4.73Jan 12, 26$4.93Jan 14, 26$5.00Jan 16, 26$4.92Jan 21, 26$5.04Jan 23, 26$5.26Jan 27, 26$5.31Jan 29, 26$5.42Feb 2, 26$5.32Feb 4, 26$5.09Feb 9, 26$5.14Feb 11, 26$4.85Feb 13, 26$4.64Feb 18, 26$4.37Feb 20, 26$4.14Feb 24, 26$4.11Feb 26, 26$4.16Mar 2, 26$3.96Mar 4, 26$3.89Mar 6, 26$4.01Mar 10, 26$3.88Mar 12, 26$3.54Mar 17, 26$3.82Mar 19, 26$3.58Mar 23, 26$3.33Mar 25, 26$3.14Mar 27, 26$3.11Mar 31, 26$3.43Apr 2, 26$3.65Apr 7, 26$3.39Apr 9, 26$3.60Apr 13, 26$3.71Apr 15, 26$3.66Apr 17, 26$3.61Apr 22, 26$3.50Apr 24, 26$3.38Apr 28, 26$3.52Apr 30, 26$3.34May 4, 26$3.52May 6, 26$3.57May 8, 26$3.26May 12, 26$3.55May 14, 26$3.43May 18, 26$3.25May 20, 26$3.30May 22, 26$3.34May 28, 26$3.43Jun 1, 26$3.22Jun 3, 26$3.14Jun 5, 26$3.54Jun 9, 26$4.16Jun 11, 26$4.22Jun 15, 26$4.24Jun 17, 26$3.92Jun 22, 26$3.65Jun 24, 26$3.70Jun 26, 26$3.68Jul 2, 26$3.61
$3.0052-week range$9.81
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

19.7%

Revenue growth (YoY)

59.8%

Gross margin

-$114.7M

Free cash flow (USD)

$1.3B

Net debt

4.2%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$31.9MFY 2020$66.6MFY 2021$36.8MFY 2022$83.0MFY 2023$91.4MFY 2024$489.7MFY 2025$586.3M
$31.9M$586.3M

Free cash flow by year

2019 → 2025

FY 2019$-96.6MFY 2020$-86.3MFY 2021$-268.8MFY 2022$-361.4MFY 2023$-358.7MFY 2024$-293.8MFY 2025$-114.7M
-$96.6M-$114.7M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 202222.8%FY 2023-75.9%FY 202462.2%FY 202559.8%
100.0%59.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Jun 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingTerm Loan Facility SecuredJul 1, 2026Filing
  • 6-K filingPublic Offering ClosedJun 18, 2026Filing
  • 6-K filingUnderwriting AgreementJun 17, 2026Filing
  • 6-K filingTermination of ATM ProspectusJun 15, 2026Filing
  • Quarterly reportQuarterly Report FiledJun 8, 2026Filing
  • Annual reportAnnual Report FiledJun 4, 2026Filing
  • 6-K filingFDA Inspection UpdateMay 11, 2026Filing
  • 6-K filingManagement ChangeMay 4, 2026Filing

Questions

Frequently asked questions

What is Alvotech's market cap?

Alvotech (ALVO) has a market capitalization of $1.1B.

What is ALVO's P/E ratio?

ALVO trades at a price-to-earnings ratio of 34.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying ALVO stock?

SEC Form 4 filings show no open-market insider buys at Alvotech in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

CRON

Cronos Group Inc.

$1.1B

COLL

Collegium Pharmaceutical, Inc.

$1.1B

EVO

Evotec SE

$1.1B

PCRX

Pacira BioSciences, Inc.

$925.6M

PAHC

Phibro Animal Health Corporation

$1.3B

HROW

Harrow Health, Inc.

$1.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.